Last reviewed · How we verify
Haemophilus influenza type b conjugate vaccine
Haemophilus influenza type b conjugate vaccine is a Biologic drug developed by Novartis Vaccines. It is currently FDA-approved.
At a glance
| Generic name | Haemophilus influenza type b conjugate vaccine |
|---|---|
| Sponsor | Novartis Vaccines |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Exploratory Clinical Study of MT-2301 (PHASE2)
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies (PHASE3)
- A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants (PHASE2)
- Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations (PHASE4)
- Phase 3 Study of BK1310 in Healthy Infants (PHASE3)
- Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children (PHASE2)
- Confirmatory Study of BK1310 in Healthy Infants (PHASE3)
- Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Haemophilus influenza type b conjugate vaccine CI brief — competitive landscape report
- Haemophilus influenza type b conjugate vaccine updates RSS · CI watch RSS
- Novartis Vaccines portfolio CI
Frequently asked questions about Haemophilus influenza type b conjugate vaccine
What is Haemophilus influenza type b conjugate vaccine?
Haemophilus influenza type b conjugate vaccine is a Biologic drug developed by Novartis Vaccines.
Who makes Haemophilus influenza type b conjugate vaccine?
Haemophilus influenza type b conjugate vaccine is developed and marketed by Novartis Vaccines (see full Novartis Vaccines pipeline at /company/novartis-vaccines).
What development phase is Haemophilus influenza type b conjugate vaccine in?
Haemophilus influenza type b conjugate vaccine is FDA-approved (marketed).